Track ProPhase Labs, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

ProPhase Labs, Inc. PRPH · Stock Open ProPhase Labs, Inc. in new tab

0.0586 USD
Add to portfolio
EPS
-1.85
P/B
-1.36
ROE
-331.81
Beta
0.07
ProPhase Labs, Inc. logo

ProPhase Labs, Inc.

🧾 Earnings Recap – Q3 2025

ProPhase Labs, Inc. reported significant strategic progress in Q3 2025, including the successful initiation of bankruptcy proceedings for underperforming lab subsidiaries and enhanced efforts to recover $150 million in underpaid insurance claims related to COVID testing.

  • Bankruptcy proceedings for inefficient COVID lab subsidiaries were officially greenlit, enabling a strategic reset.
  • Crown Medical is now pursuing collection of $150 million in outstanding claims from insurance companies, targeting underpaid COVID test reimbursements.
  • The company highlights a disconnect between market cap and underlying asset value, with plans to unlock this potential moving forward.
  • Strong emphasis placed on the importance of investor participation in upcoming proxy voting to support strategic initiatives.
📅
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateAug. 12, 2026
EPS-1.85
Book Value-0.04
Price to Book-1.36
Debt/Equity245.67
% Insiders2.368%
Growth
Revenue Growth-0.67%
Estimates
Forward P/E0.13
Forward EPS0.48

DCF Valuation

Tweak assumptions to recompute fair value for ProPhase Labs, Inc. (PRPH)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

ProPhase Labs, Inc. Logo ProPhase Labs, Inc. Analysis (PRPH)

United States Health Care Official Website Stock

Is ProPhase Labs, Inc. a good investment? ProPhase Labs, Inc. (PRPH) is currently trading at 0.0586 USD.

Earnings Schedule: ProPhase Labs, Inc. is expected to release its next earnings report on Aug. 12, 2026. The market consensus estimate for Forward EPS is 0.48.

Investor FAQ

Does ProPhase Labs, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is ProPhase Labs, Inc.?

ProPhase Labs, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 12, 2026. The company currently has a trailing EPS of -1.85.

Company Profile

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, including the genes and chromosomes in deoxyribonucleic acid; DNA Expand, a platform that allows consumers to upload their DNA data from previous DNA tests obtained from other service providers; and LB-1 and LB-2 for the treatment of cancer, inflammatory diseases or symptoms and memory related syndromes, diseases or symptoms, including dementia and Alzheimer's disease. In addition, the company provides Nebula focuses on genomics testing technologies a comprehensive method for analyzing entire genomes, including the genes and chromosomes in deoxyribonucleic acid (DNA). It offers its genome sequencing products to consumers online with plans to sell in food, drug, and mass retail stores. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Uniondale, New York.

Exchange Ticker
NMS (United States) PRPH
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2022
6.00 USD
June 3, 2022 3.0000
March 10, 2022 3.0000
▸2021
3.00 USD
June 3, 2021 3.0000
▸2019
5.00 USD
Dec. 12, 2019 2.5000
Jan. 24, 2019 2.5000
▸2018
11.00 USD
June 6, 2018 1.0000
June 5, 2018 10.0000
Stock Splits
Split Date Split Ratio to 1
Jan. 23, 1997 2.000000
Dec. 22, 2025 0.100000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion